Mitchell Capital Management Co. Decreases Stake in HCA Healthcare, Inc. $HCA

Mitchell Capital Management Co. reduced its stake in HCA Healthcare, Inc. (NYSE:HCA) by 11.9% in the 2nd quarter, HoldingsChannel.com reports. The firm owned 16,268 shares of the company’s stock after selling 2,202 shares during the period. HCA Healthcare comprises about 1.1% of Mitchell Capital Management Co.’s holdings, making the stock its 24th biggest position. Mitchell Capital Management Co.’s holdings in HCA Healthcare were worth $5,875,000 at the end of the most recent reporting period.

Other hedge funds and other institutional investors have also recently modified their holdings of the company. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. increased its holdings in HCA Healthcare by 11.9% in the 1st quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 25,454 shares of the company’s stock worth $8,796,000 after buying an additional 2,698 shares during the period. Park Place Capital Corp increased its holdings in HCA Healthcare by 2,336.0% in the 2nd quarter. Park Place Capital Corp now owns 1,218 shares of the company’s stock worth $474,000 after buying an additional 1,168 shares during the period. Harrell Investment Partners LLC increased its holdings in HCA Healthcare by 176.3% in the 2nd quarter. Harrell Investment Partners LLC now owns 1,815 shares of the company’s stock worth $695,000 after buying an additional 1,158 shares during the period. Brown Advisory Inc. increased its holdings in HCA Healthcare by 53.9% in the 1st quarter. Brown Advisory Inc. now owns 4,630 shares of the company’s stock worth $1,600,000 after buying an additional 1,622 shares during the period. Finally, Farther Finance Advisors LLC increased its holdings in HCA Healthcare by 26.9% in the 1st quarter. Farther Finance Advisors LLC now owns 1,141 shares of the company’s stock worth $395,000 after buying an additional 242 shares during the period. 62.73% of the stock is owned by hedge funds and other institutional investors.

Insiders Place Their Bets

In other HCA Healthcare news, EVP Michael S. Cuffe sold 3,836 shares of the firm’s stock in a transaction on Monday, September 8th. The stock was sold at an average price of $418.84, for a total value of $1,606,670.24. Following the transaction, the executive vice president owned 31,503 shares in the company, valued at approximately $13,194,716.52. This trade represents a 10.85% decrease in their position. The sale was disclosed in a document filed with the SEC, which is accessible through the SEC website. Insiders own 1.30% of the company’s stock.

HCA Healthcare Price Performance

Shares of NYSE:HCA opened at $414.73 on Monday. HCA Healthcare, Inc. has a 1 year low of $289.98 and a 1 year high of $439.01. The firm has a market capitalization of $97.04 billion, a price-to-earnings ratio of 17.43, a price-to-earnings-growth ratio of 1.31 and a beta of 1.40. The business’s 50 day moving average price is $405.12 and its 200-day moving average price is $376.08.

HCA Healthcare (NYSE:HCA) last announced its quarterly earnings data on Friday, July 25th. The company reported $6.84 earnings per share for the quarter, beating analysts’ consensus estimates of $6.20 by $0.64. The company had revenue of $18.61 billion for the quarter, compared to analyst estimates of $18.49 billion. HCA Healthcare had a negative return on equity of 7,363.11% and a net margin of 8.21%.The firm’s revenue for the quarter was up 6.4% on a year-over-year basis. During the same quarter last year, the firm posted $5.50 EPS. HCA Healthcare has set its FY 2025 guidance at 25.500-27.000 EPS. On average, sell-side analysts expect that HCA Healthcare, Inc. will post 24.98 earnings per share for the current year.

HCA Healthcare Dividend Announcement

The company also recently disclosed a quarterly dividend, which was paid on Tuesday, September 30th. Shareholders of record on Tuesday, September 16th were issued a $0.72 dividend. The ex-dividend date was Tuesday, September 16th. This represents a $2.88 dividend on an annualized basis and a yield of 0.7%. HCA Healthcare’s dividend payout ratio (DPR) is presently 12.11%.

Wall Street Analysts Forecast Growth

A number of brokerages have recently commented on HCA. Robert W. Baird raised their price objective on shares of HCA Healthcare from $380.00 to $423.00 and gave the stock a “neutral” rating in a research note on Thursday, August 14th. JPMorgan Chase & Co. raised their price objective on shares of HCA Healthcare from $360.00 to $370.00 and gave the stock a “neutral” rating in a research note on Monday, August 4th. Wells Fargo & Company raised their price objective on shares of HCA Healthcare from $375.00 to $412.00 and gave the stock an “equal weight” rating in a research note on Tuesday, October 7th. KeyCorp raised their price objective on shares of HCA Healthcare from $370.00 to $465.00 and gave the stock an “overweight” rating in a research note on Wednesday. Finally, Bank of America raised their price objective on shares of HCA Healthcare from $375.00 to $410.00 and gave the stock a “neutral” rating in a research note on Wednesday, September 10th. One analyst has rated the stock with a Strong Buy rating, eight have issued a Buy rating and nine have issued a Hold rating to the company’s stock. According to MarketBeat, the stock has an average rating of “Moderate Buy” and an average price target of $422.31.

About HCA Healthcare

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.